Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Emerging evidence from recent in vitro studies and clinical trials indicates an inverse correlation between SCFA concentrations in the gut and the prevalence of disorders, including colorectal cancer, IBD, and diabetes
Published in the journal Clinical and Translational Medicine , the results of this study show that older humans taking GlyNAC for 24 weeks saw improvements in many characteristic defects of aging, including glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, body fat, genomic toxicity, muscle strength, gait speed, exercise capacity and cognitive function
the volume chosen sets the working concentration
For control experiments, 80 samples from 80 patients were treated for non-infectious disease causes
